Clinical studies recruiting near San Carlos

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Miltenyi Biomedicine GmbH · NCT04844866 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · H. Lundbeck A/S · NCT05897320 First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve
NA · Epygon · NCT04775108 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice
Phase N/A · Outcomes'10 · NCT07252765 Long Term Effect of Brain Stimulation in PPA
NA · Hospital San Carlos, Madrid · NCT07158216 A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · Deciphera Pharmaceuticals, LLC · NCT05957367 Spanish Registry of Esophagogastric Cancer
Phase N/A · Fundación Sociedad Española de Oncologia Médica · NCT04958720 Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
NA · Francisco J. Blanco · NCT07678112 iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)
NA · Iria Grande · NCT05655390 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Amgen · NCT04221542 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · Fundación GECP · NCT05398094 Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis
NA · Grupo Español de Investigación en Diagnóstico y Tratamiento · NCT07465848 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Bristol-Myers Squibb · NCT06976216 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · AgNovos Healthcare, LLC · NCT04796350 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Artios Pharma Ltd · NCT04657068 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Daiichi Sankyo · NCT06330064 A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metast
Phase 1/Phase 2 · Merck Sharp & Dohme LLC · NCT05562830 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Merck Sharp & Dohme LLC · NCT06833073 Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Phase 3 · European Organisation for Research and Treatment of Cancer - · NCT05974774 Effect of a Probiotic Formula in Mild Cognitive Impairement
NA · Universidad Complutense de Madrid · NCT06670807 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Exciva GmbH · NCT07284472 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Bristol-Myers Squibb · NCT05489705 A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic P
Phase 1 · Genentech, Inc. · NCT05800665 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Merck Sharp & Dohme LLC · NCT06623422 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846

Look up another city

Look up another condition